Fig. 5.
GFP+ human cells present in NOD/SCID-β2m−/− mice that received transplants of MSCV-HS2-β-globin-GFP–-transduced human cord blood cells 3 weeks previously.
Mice received transplants of cells transduced as described in the text and marrow cells removed 3 weeks later were then analyzed by FACS for GFP and expression of human lineage–specific markers. Results shown here are for cells from a representative mouse. The top left panel shows results for cells not stained with the antihuman antibodies.
